The Department of Surgery at the University of Texas Medical School at Houston
Department of Surgery
MHH Life Flight

Biography

Department of Surgery - Trauma


Jeanette M. Podbielski, RN, BSN

Senior Research Nurse
Department of Surgery
Division of Acute Care Surgery
The University of Texas Medical School at Houston
Center for Translational Injury Research

Back

Education:

1984 Grand View College, Bachelor of Science in Nursing

Professional Experience:

1990 + Transplant Coordinator, University of Texas Health Science Center,
Houston, Texas

January 1990: Head Nurse of Transplant Outpatient Clinic

October 1991: Research Study Coordinator

November 1993: Promoted to Senior Research Nurse

April 1997: Promoted to Supervisor of Research Nurse Staff

January 2008 – Transferred part time to Trauma Surgery

September 2008 – Transferred to Center for Translational Injury Research

1988- 1990 Director of Nursing at Southwest Houston Dialysis Center, Rosenberg Dialysis
Center, Gulf Coast Mobile Acute Dialysis Unit, and Home Staff Assisted
Hemodialysis Unit

1986-1988 Staff Nurse at Baylor University Medical Center, Dallas, Texas on a 38 bed
unit for liver and kidney transplant patients and vascular surgical patients.

September 1987: Promoted to Charge Nurse
November 1987: Promoted to Clinical Nurse II

1984-1986 Staff R.N. at Golden Triangle Dialysis Unit, Beaumont, Texas
January 1985: Promoted to Charge Nurse for A.M. shift
April 1985: Promoted to Charge Nurse for the facility

1984 Staff R.N. at St. Elizabeth Hospital, Beaumont, Texas

NURSING LICENSE:

Active: State of Texas

PUBLICATIONS AND PRESENTATIONS:

  1. Lewis, R., PODBIELSKI, J., Sprayberry, S., Munsell, M., Katz, S., Rubin, M., Kimball, P., Van Buren, C., Kerman, R., Kahan, B. Stability of renal allograft glomerular filtration rate associated with long-term use of Cyclosporine A. Transplantation 55: 1014-1017, 1993.
  2. Lewis, R., PODBIELSKI, J. Evolution of Native Kidney and Renal Transplant Function in Patients Receiving Long-Term Cyclosporine Therapy.
    Presented at Issues of Transplantation, A Multidisciplinary Approach, Houston, Texas, April, 1992.
  3. Kerman, R., Kimball, P., Van Buren, C., Katz, S., Lewis, R., McClain, J., PODBIELSKI, J.,
    Williams, J., Kahan, B. Influence of HLA matching and pretransplant blood transfusions on rejections and short and long-term primary cadaveric allograft survival. Transplantation 56: 1242-1247, 1993.
  4. Kerman, R., Kimball, P., Van Buren, C., Lewis, R., Katz, S., McClain, J., PODBIELSKI, J., Williams, J, Kahan, B. Influence of HLA matching and pretransplant blood transfusions on rejections and short and long-term primary cadaveric allograft survival. Transplantation.
  5. PODBIELSKI, J., McClain, J. New Immunological Drug Therapy: Brequinar and Rapamycin
    Presented at Organ Transplantation in 21st Century, Houston, Texas, April, 1992.
  6. Kerman, R., Kimball, P., Lindholm, A., Van Buren, C., Katz, S., Lewis, R., PODBIELSKI, J., Williams, J., Kahan, B. Immune risk factors: impact on the incidence and diagnosis of rejection. Transplant Proc. 25 (Suppl 3): 23 - 25, 1993.
  7. Lewis, R., PODBIELSKI, J. Munsell, M., Katz, S., Van Buren, C., Kerman, R., Kahan, B., Optimization and long-term evaluation of renal function in Sandimmune-treated renal allograft recipients. Transplant Proc. 25 (No. 4, Supp. 3) 10- 12, 1993.
  8. Lewis, R., PODBIELSKI, J., Munsell, M., Katz, S., Van Buren, C., Kerman, R., Kahan, B. Stability of renal allograft glomerular filtration rate in the cyclosporine era: two-year follow up. Transplant Proc. 1994
  9. Kahan, B., PODBIELSKI, J., King, P., Van Buren, C., Katz, S., Jaffe, B., Lewis, R., Joshi, A., Labriola, D., Chou. C., Kornhauser, D. The therapeutic window of brequinar and clinical renal transplantation.
  10. Kahan, B., PODBIELSKI, J., Napoli, K., Katz, S., Meier-Kriesche, H.-U., and Van Buren, C. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 66:1040-1046, 1998.
  11. Podder, H., PODBIELSKI, J., Hussein, I., Katz, S.M., Van Buren, C.T., and Kahan, B.D. Sirolimus overcomes rejection proactivity of African-American patients. Transplant Internantional (in preparation).
  12. Kahan, B., Napoli, K., Kelly, P. PODBIELSKI, J., Hussein, I., Katz, S.M., Van Buren, C.T.: Therapeutic drug monitoring of sirolimus: Correlations with efficacy and toxicity. Clin.Transplant. 14: 97-109, 2000.
  13. PODBIELSKI, J. Wyeth-Ayerst Pharmaceuticals Clinical Symposium. Presented at NATCO 25th Anniversary Meeting, Orlando, Florida, August ,2000.
  14. PODBIELSKI , J. Sirolimus, a New Pathway to Immunosuppression. Presented at NATCO 25th Anniversary Meeting, Orlando, Florida, August, 2000.
  15. PODBIELSKI, J., Schoenberg, L. Use of Sirolimus in Kidney Transplantation. Progress in Transplantation 11: 29-32, 2001.
  16. PODBIELSKI, J. Update on New Immunosuppressives in Transplantation. Presented at ANNA Chapter Meeting, Columbia, Missouri, August 2001.
  17. Podder, H., PODBIELSKI, J., Hussein, Il, Katz, S.M., Van Buren, C.T., and Kahan, B.D.: Impact of sirolimus on renal transplant outcomes in African-Americans. Transplant. Proc. 33: 1226, 2001.
  18. Kahan, B.D., Napoli, K.L., PODBIELSKI, J., Hussein, I., Katz, S.M., and Van Buren, C.T.: Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes. Transplant Proc. 33: 1278, 2001.
  19. Podder, H., PODBIELSKI, J., Hussein, I., Katz, S.M., Van Buren, C.T., and Kahan, B.D.: Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transpl. Int. 14: 135-142, 2001.
  20. PODBIELSKI, J. Sirolimus Clinical Trials. Presented at Wyeth Ayerst Preceptorship Programs, Houston, Texas, 1998 to present as scheduled.
  21. Kahan, B.D., Knight, R., Schoenberg, L., PODBIELSKI, J., Kerman, R.H., Mahalati, K., Yakupoulu, Y, Aki, F.T., Katz, S.M., and Van Buren, C. T.: Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience. Transplant Proc. 35:25S-36S, 2003
  22. Kahan, B.D., PODBIELSKI, J., Schoenberg, L., Lai, D: Impactof simultaneous versus spaced dosing of sirolimus in combination with cyclosporine. Transplantation. (in preparation)
  23. PODBIELSKI, J.: Quality of Life. Presented via teleconference to Canadian Transplant Nursing Seminar, October 2002.
  24. PODBIELSKI, J.: Managing the complications of Sirolimus therapy. Presented to Dallas Nephrologist Seminar, November 12, 2002.
  25. PODBIELSKI, J.: Participated on Novartis Transplant Coordinator Advisory Committee. January 2001.
  26. PODBIELSKI, J.: Participated on Wyeth Transplant Coordinator Advisory Committee. December 7, 2004.
  27. PODBIELSKI, J.: Presented “Preparing for an FDA Audit” to Association of Clinical Research Nurses at University of Texas Health Science Center at Houston, Texas, 2003 to present as scheduled.
  28. Podder, H., PODBIELSKI, J., Katz, S, Van Buren, C.T., and Kahan, B.D.: Use of sirolimus overcomes risk factor of African-American race. The British Journal of Surgery. Vol. 85, Suppl 2, July 1998, p. 74.
  29. PODBIELKSI, J.: Participated in University of Texas Medical School Research Nurse Advisory Committee. December 2005 to present.
  30. PODBIELSKI, J.: Presented “Target Blood Levels” to RAD 2309 Study Coordinators for Novartis Pharmaceuticals Inc. March 23, 2007.

Contact Information

Jeanette Podbielski, RN, BSN
  • Jeanette Podbielski, RN, BSN

  • Senior Research Nurse Department of Surgery
    Division of Acute Care Surgery
    The University of Texas Medical School at Houston

  • Center for Translational Injury Research

  • 6410 Fannin Street
    UPB 1100
    Houston, Texas 77030

  • phone: (713) 704-6331
    e-mail: Jeanette.M.Podbielski
    @uth.tmc.edu